Researchers influence CDC’s clarification on prescribing opioids for cancer pain

Researchers influence CDC’s clarification on prescribing opioids for cancer pain

To reduce the number of people who may misuse, abuse, or overdose from opioids, multiple national ag...
read more
Lower rates of opioid prescriptions in states that implemented medical cannabis use laws

Lower rates of opioid prescriptions in states that implemented medical cannabis use laws

Using data from privately-insured adults, new find...
read more
FDA approves first drug to help tame cluster headaches

FDA approves first drug to help tame cluster headaches

(HealthDay)— The U.S. Food and Drug Administrati...
read more
FDA approves first gene therapy for spinal muscular atrophy

FDA approves first gene therapy for spinal muscular atrophy

(HealthDay)—The first gene therapy has been appr...
read more
Doping soldiers so they fight better—is it ethical?

Doping soldiers so they fight better—is it ethical?

The military is constantly using technology to bui...
read more
Molecular basis of brain dysfunction and embryo malformation associated with thalidomide

Molecular basis of brain dysfunction and embryo malformation associated with thalidomide

In the late 1950s, thalidomide was prescribed as a...
read more
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

LA JOLLA, Calif., April 15, 2019 (GLOBE NEWSWIRE) ...
read more
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas

Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas

WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) &#...
read more
Insurers’ denials of opioid coverage spurs CDC to clarify guidelines

Insurers’ denials of opioid coverage spurs CDC to clarify guidelines

(HealthDay)—People with severe pain from cancer ...
read more
Gabapentin and pregabalin become class C drugs

Gabapentin and pregabalin become class C drugs

An expert in mental health and addiction at the Un...
read more